These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 35201647)

  • 21. Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies.
    Gentile P
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Review of the post-COVID-19 syndrome associated to acute telogen effluvium].
    Chávez-Chavira G
    Rev Med Inst Mex Seguro Soc; 2023 Jul; 61(4):496-501. PubMed ID: 37540705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of SARS-CoV-2 infection and its vaccines in various types of hair loss.
    Aryanian Z; Balighi K; Hatami P; Afshar ZM; Mohandesi NA
    Dermatol Ther; 2022 Jun; 35(6):e15433. PubMed ID: 35266262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alopecia in patients with COVID-19: A systematic review and meta-analysis.
    Nguyen B; Tosti A
    JAAD Int; 2022 Jun; 7():67-77. PubMed ID: 35224518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the safety and efficacy of platelet-rich plasma in the treatment of female patients with chronic telogen effluvium: A randomised, controlled, double-blind, pilot clinical trial.
    El-Dawla RE; Abdelhaleem M; Abdelhamed A
    Indian J Dermatol Venereol Leprol; 2023; 89(2):195-203. PubMed ID: 35593290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study.
    Awad NEHA; Obaid ZM; Zaky MS; Elsaie ML
    Ir J Med Sci; 2024 Apr; 193(2):761-767. PubMed ID: 37704885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the relationship of digital phototrichogram findings of patients with diffuse hair loss with blood TSH, ferritin and vitamin B12 levels.
    Bilik L; Kokcam I; Esen M
    North Clin Istanb; 2024; 11(1):38-44. PubMed ID: 38357319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review.
    Gruenstein D; O'Mara M; Pa SH; Levitt J; Pa SL; Tom J; Leger M
    Dermatol Online J; 2021 Oct; 27(10):. PubMed ID: 35130383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium.
    Yorulmaz A; Hayran Y; Ozdemir AK; Sen O; Genc I; Gur Aksoy G; Yalcin B
    J Cosmet Dermatol; 2022 Jun; 21(6):2610-2617. PubMed ID: 34449961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time of onset and duration of post-COVID-19 acute telogen effluvium.
    Abrantes TF; Artounian KA; Falsey R; Simão JCL; Vañó-Galván S; Ferreira SB; Davis TL; Ridenour W; Goren A; Tosti A; Wambier CG
    J Am Acad Dermatol; 2021 Oct; 85(4):975-976. PubMed ID: 34302903
    [No Abstract]   [Full Text] [Related]  

  • 31. Postpartum Telogen Effluvium Unmasking Additional Latent Hair Loss Disorders.
    Galal SA; El-Sayed SK; Henidy MMH
    J Clin Aesthet Dermatol; 2024 May; 17(5):15-22. PubMed ID: 38779373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
    Zímová J; Zímová P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with hair loss (androgenetic alopecia, AGA or FAGA or telogen effluvium). A prospective, randomized, 3-month, controlled, assessor-blinded study.
    Milani M; Colombo F;
    Skin Res Technol; 2023 Jun; 29(6):e13381. PubMed ID: 37357646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19-induced hair shedding and related risk factors: A Saudi perspective.
    Bukhari AE; AlDosari DA; AlDosari MA; Muqrin RF; Moazin OM; Almutlq MM; Altalhab SM; Alharithy RS; Alkhalifah AI
    J Family Med Prim Care; 2023 Dec; 12(12):3304-3311. PubMed ID: 38361868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of Hair Loss After COVID-19 Infection in Makkah Region, Saudi Arabia.
    Abdulwahab RA; Aldajani BM; Natto NK; Janabi AM; Alhijaili OI; Faqih NT; Alharbi A
    Cureus; 2022 Sep; 14(9):e29285. PubMed ID: 36277546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the effects of a hair lotion in women with acute telogen effluvium: a randomized controlled study.
    Turlier V; Darde MS; Loustau J; Mengeaud V
    J Eur Acad Dermatol Venereol; 2021 Nov; 35 Suppl 2():12-20. PubMed ID: 34668237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covid Induced Telogen Effluvium (CITE): An Insight.
    Inamadar AC
    Indian Dermatol Online J; 2022; 13(4):445-448. PubMed ID: 36262583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review.
    Daunton A; Harries M; Sinclair R; Paus R; Tosti A; Messenger A
    Am J Clin Dermatol; 2023 Jul; 24(4):513-520. PubMed ID: 37052778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential cyclic changes of hair roots revealed by dermoscopy demonstrate a progressive mechanism of diffuse alopecia areata over time.
    Zhang X; Ye Y; Zhu Z; Yang Y; Cao H; McElwee KJ; Ling Y
    Exp Dermatol; 2020 Mar; 29(3):223-230. PubMed ID: 30307062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hair and nail manifestations of COVID-19.
    Tammaro A; Adebanjo GAR; Parisella FR; Luzi F; Scarabello A
    J Cosmet Dermatol; 2022 Apr; 21(4):1339-1346. PubMed ID: 35032337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.